Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase

Details for Australian Patent Application No. 2008304620 (hide)

Owner Bayer HealthCare LLC

Inventors Ma, Xin; Zhang, Zhonghua; Qi, Ning; Magnuson, Steven; Wickens, Philip

Agent Griffith Hack

Pub. Number AU-A-2008304620

PCT Pub. Number WO2009/042543

Priority 60/995,147 25.09.07 US

Filing date 22 September 2008

Wipo publication date 2 April 2009

International Classifications

A01N 43/64 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds - having rings with three nitrogen atoms as the only ring hetero atoms

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/042543 Priority application(s): WO2009/042543

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008304622-MRI phase visualization of interventional devices

2008304619-Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis